z-logo
open-access-imgOpen Access
Addition of Palbociclib to Adjuvant Endocrine Therapy Provides No Benefit
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000721360.06586.4f
Subject(s) - palbociclib , breast cancer , medicine , oncology , adjuvant , adjuvant therapy , endocrine system , cancer , metastatic breast cancer , hormone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here